Concepedia

Michael Ronellenfitsch

MR

45

Publications

2.1K

Citations

26

H-Index

2009

Active since

Affiliations

Goethe University Frankfurt(Current)

University Hospital Frankfurt

Deutschen Konsortium für Translationale Krebsforschung

Frankfurt Cancer Institute

German Cancer Research Center

Michael Ronellenfitsch is an author at Goethe University Frankfurt specializing in medicine, glioma, and tumor biology.

ORCID

Top concepts

Publications per year

2009–2024

45

Publications

45

mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy

Markus Weiler, Jonas Blaes, Stefan Pusch et al. · Proceedings of the National Academy of Sciences · 2013 · 195 citations · Full text

Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O<sup>6</sup>-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial

Ulrich Herrlinger, Niklas Schäfer, Astrid Weyerbrock et al. · Journal of Clinical Oncology · 2016 · 194 citations

The Pan-Bcl-2 Inhibitor (−)-Gossypol Triggers Autophagic Cell Death in Malignant Glioma

Valerie Voss, Christian Senft, Verena Lang et al. · Molecular Cancer Research · 2010 · 187 citations · Full text

, , +18

Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases

Patrick N. Harter, Simon Bernatz, Alexander Scholz et al. · Oncotarget · 2015 · 122 citations · Full text

ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma

Marlies Wagner, Nina von Mettenheim, Patrick N. Harter et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 86 citations

, , +10

Rows per page

1–5 of 45